Another significant research reported that the expression level of MEG3 in normal lung tissues was higher than that in NSCLC tissues, and the downregulation of MEG3 might be an adverse prognostic factor in patients with NSCLC (Zhang et al., 2017a). Here, MEG3 is linked to non-small cell lung carcinoma.